Magnetic resonance imaging offered a 29 percent higher sensitivity than CT for differentiating liver metastases, but CT provided 12 percent higher sensitivity than MRI for assessing vascular invasion, according to a new 40-study meta-analysis.
|Articles|February 28, 2001
FDA clears software, MRI coil, and scanner
Several products have gained clearance for marketing in the U.S. Passing FDA muster were Vital Images' Vscore, a cardiac CT option featuring AutoGate for use on the company's Vitrea 2 workstation; Surgi-Vision's intravascular MRI coil; and Marconi's
Advertisement
Several products have gained clearance for marketing in the U.S. Passing FDA muster were Vital Images' Vscore, a cardiac CT option featuring AutoGate for use on the company's Vitrea 2 workstation; Surgi-Vision's intravascular MRI coil; and Marconi's Infinion 1.5T MRI scanner. Vital Images' VScore with AutoGate determines the phase of the cardiac cycle at which each CT slice was recorded, automatically selecting the images of the heart least affected by cardiac motion without an ECG signal. Called Intercept, the disposable coil from Surgi-Vision is designed to be threaded into arteries or veins to detect early signs of blood vessel disease in conjunction with standard MRI scanners. Infinion 1.5T is a short-bore whole-body MRI system.
2/28/01, Issue # 1504, page 6.
Advertisement
Related to this article
In a recent interview with Diagnostic Imaging, Joseph Cavallo, MD, MBA, offered insights on post-deployment monitoring with AI, the potential for improved workflow efficiency and the ongoing challenge of balancing essential clinical skills and AI literacy in the training of radiology residents and fellows.
Does fractional flow reserve (FFR) or quantitative plaque burden from CCTA provide greater prognostic insight into coronary disease?
In the first of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD share insights on the utility of AI in breast imaging with respect to potential advantages, current concerns and future directions.
Catch up on the most-well viewed radiology content in September 2026.
The BiPASS program, which combines 68Ga PSMA PET imaging with prostate MRI prior to the use of prostate biopsy, is slated to be evaluated in an impending phase 3 trial.
For patients with localized prostate cancer, stereotactic body radiotherapy (SBRT) offered comparable freedom from biochemical/clinical failure at eight years and nearly 40 percent lower urinary incontinence in comparison to radical prostatectomy, according to research presented at the ASTRO conference.
Catch up on the most well-viewed video interviews from Diagnostic Imaging in September 2026.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
The Reading Room Podcast: Current Perspectives, Challenges and Possibilities with AI in Breast Imaging, Part 1
2
FDA Grants Fast Track Designation for Pre-Biopsy Use of PSMA PET and MRI for Prostate Cancer Detection
3
Current Perspectives on Integrating AI into Radiology
4
Radiology and Building the Alzheimer’s Care Pathway of the Future
5